Artmed Healthcare Profile
Key Indicators
- Authorised Capital ₹ 108.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 101.45 Cr
as on 16-11-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 15.63%
(FY 2023)
- Profit 773.81%
(FY 2023)
- Ebitda 79.66%
(FY 2023)
- Net Worth 20.64%
(FY 2023)
- Total Assets 2.89%
(FY 2023)
About Artmed Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 108.00 Cr and a paid-up capital of Rs 101.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Artmed Healthcare Private Limited India is Rimjhim Mishra as COMPANY SECRETARY. Rastogi Atul and Jason Henne serve as directors at the Company.
- CIN/LLPIN
U74999TG2016PTC110459
- Company No.
110459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Artmed Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rimjhim Mishra  | Company Secretary | 30-Sep-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jason Henne  | Director | 19-Aug-2021 | Current |
| Rastogi Atul | Director | 04-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Artmed Healthcare.
Artmed Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.63% increase. The company also saw a substantial improvement in profitability, with a 773.81% increase in profit. The company's net worth Soared by an impressive increase of 20.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Artmed Healthcare?
In 2023, Artmed Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
American Institute Of Pathology And Laboratory Sciences Private LimitedActive 17 years 1 monthRastogi Atul and Jason Henne are mutual person
Cancer Treatment Services Hyderabad Private LimitedActive 18 years 1 monthRastogi Atul and Jason Henne are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Artmed Healthcare?
Artmed Healthcare has a workforce of 486 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Artmed Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artmed Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
